▶ GHRP-6 · SUBTOPIC · SAFETY PROFILE
GHRP-6 Safety Profile
For Laboratory Research Use Only. This page summarises observed adverse events and regulatory status reported in the peer- reviewed literature. It is not medical advice and does not recommend any human use of GHRP-6.
OBSERVED ADVERSE EVENTS IN LITERATURE
The following adverse events have been observed in trials or animal studies of GHRP-6. Severity, frequency, and attribution depend on the source publication.
- Strong appetite stimulation
- Mild cortisol elevation
- Mild prolactin elevation
- Flushing
- Injection-site reactions
DRUG INTERACTIONS
The following interactions are reported in or theorised from the published mechanism for GHRP-6.
- Concurrent rhGH not recommended
- Glucocorticoids may blunt response
CONTRAINDICATIONS REPORTED IN LITERATURE
Contraindications recorded for GHRP-6 in the published record:
- Active malignancy
- Pituitary tumor
- Pregnancy/lactation
FDA REGULATORY STATUS
Not FDA-approved. Research-use only.
WADA REGULATORY STATUS
Prohibited at all times under WADA Section S2 (growth-hormone-secretagogue sub-category).
SAFETY Q+A FROM LITERATURE
▶ Is GHRP-6 FDA-approved?
No. Research-use only.
▶ Is GHRP-6 WADA-prohibited?
Yes. GHRP-6 is prohibited at all times under WADA Section S2 in the growth-hormone-secretagogue sub-category.
▶ How is GHRP-6 paired with a GHRH analog?
GHRP-6 + CJC-1295 No DAC engages both upstream regulators of GH release. The two pathways are independent and complementary; combined activation amplifies the GH pulse synergistically. Less commonly used than ipamorelin + CJC-1295 due to GHRP-6's appetite and stress-hormone side effects.
CITED LITERATURE
The safety statements above are drawn from the following peer-reviewed sources. Refer to the originals for adverse- event tables, attribution, and full context.
- Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984. link
- Smith RG, Van der Ploeg LH, Howard AD, et al.. Peptidomimetic regulation of growth hormone secretion. Endocr Rev 1997. link
RELATED PAGES
▶ LAST UPDATED · 2026-05-25